Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL StudyRyota Saito, Kunihiko Kobayashi, Satoshi Oizumi et al.|European Journal of Cancer|2023Cited by 27
A Phase Ⅱ Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non–Small-Cell Lung Cancer: TORG2241 (UBE-Q)Shinji Nakamichi, Hiroaki Okamoto, Kaoru Kubota et al.|Clinical Lung Cancer|2023Cited by 6
P2.23-02 Prospective Observational Study of Cachexia and Its Effect on Systemic Therapy in Patients with Previously-Untreated Advanced NSCLC (NEJ050A)Naoki Furuya, K. Takahashi, Kiyonori Miura et al.|Journal of Thoracic Oncology|2023Cited by 2